International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Related Enduring Materials

Enduring Materials

Session 1: Pharmacokinetics & Pharmacodynamics of Approved TB drugs in Special Populations -

Clinical Pharmacology Issues for Pediatric TB

Sharon Nachman, MD

SUNY Health Science Center Stony Brook / IMPAACT Network, United States

Slideset

Pharmacokinetics of rifampicin, isoniazid and pyrazinamide in children on 2010 WHO/IUATLD guideline doses

H. McIlleron

#01

Slideset

A simultaneous population pharmacokinetic analysis in Malawian adults and children of rifampicin

A. Schipani

#02

Slideset

Pharmacokinetics of rifampin among pregnant women with tuberculosis and HIV co-infection

K. Dooley

#03

Slideset

Session 2: Pharmacokinetics & Pharmacodynamics of New and Redeveloped TB Drugs -

The Critical Path to TB Drug Regimens: Advancing through a Multidisciplinary, Multipartner Approach

Klaus Romero, MD, MS

USC School of Pharmacy, USA

Slideset

Drug-drug interactions between bedaquiline and the antiretrovirals nevirapine and lopinavir/ritonavir in patients

M. Pandie

#04

Slideset

High dose rifampicin: a phase II trial comparing 10, 15 and 20 mg/kg rifampicin for two months

R. Aarnoutse

#05

Slideset

Population pharmacokinetics and bacterial dynamics of sutezolid in patients with active tuberculosis

K.B. Larson

#06

Slideset

The inhibitory potential of TB drugs on ATP-binding cassette transporters MRP1- 5, P-gp, BCRP and BSEP

L. Te Brake

#07

Slideset

Session 3: Pharmacokinetic & Pharmacodynamic Modeling -

Pharmacological Knowledge Gaps in the Treatment of TB Meningitis

Guy Thwaites, MA, MBBS, PhD, FRCP, FRCPath, FMedSci

Oxford University, UK

Slideset

A quantitative and systems pharmacology approach to dose optimization in experimental tuberculosis: opportunities and experimental data needs

M. Lyons

Slideset

A semi mechanistic pharmacokinetic-pharmacodynamic template model for studying antitubercular drug effects in vitro

O. Clewe

Slideset

Pharmacokinetics of levofloxacin in M(X)DR tuberculosis patients

N. Van’t Boveneind- Vrubleuskaya

#10

Slideset

Session 4: Drug Development and Optimization: Approaches & Tools -

Inhaled Therapy for TB

Edward Nardell, MD

Harvard Medical School, USA

Slideset

Intra cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis

R. Kempker

#11

Slideset

Anti-Tuberculosis Activity of Pyrazinamide Varies by Lesion Type in C3heb/Fej Mice

Lanoix, J.-P

#12

Slideset

Real-time and non-invasive, multi-compartment pharmacokinetics of 11c-rifampin in mycobacterium tuberculosis infected mice using dynamic positron emission tomography

V.P. DeMarco

#13

Slideset

Computational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment

M. Lyons

#14

Slideset

Overview

Welcome

Dear colleagues,

The 7th edition of the International Workshop on Pharmacology of Tuberculosis Drugs, which has been held on 5 September 2014 in Washington DC, USA, preceding the ICAAC 2014, has been a tremendous success.

Excellent presentations by the invited speakers and the poster presentors have created a very interesting program.

We would like to thank all attendees for their participation and input and we would like to express our appreciation to everyone who took the time to fill in the evaluation form at the end of the conference. Thank you for your feedback and suggestions!

Kind regards,

The Organizing Committee